NASDAQ: DVAX       Dynavax Technologies
Last Price Today's Change   Day's Range   Trading Volume
5.20   -0.09 (1.70%)  5.15 - 5.665  621,454


Avg Volume (4 weeks):1,160,222
4 Weeks Range:5.15 - 6.36
4 Weeks Price Volatility (%):
52 Weeks Range:2.595 - 11.44
52 Weeks Price Volatility (%):
Average Price Target: 5.00
Price Target Upside/Downside: -0.20


No recent Headlines for this stock.

Business Background

Dynavax Technologies Corp is a clinical-stage biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. It's current product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. Dynavax operates in the business segment the discovery and development of biopharmaceutical products. Its Toll-like Receptor Immune Modulation Platform technology play a vital role in innate immunity and subsequent adaptive immunity. Signaling through these receptors is triggered by the binding of a variety of pathogen-associated molecules and is essential to the generation of innate immunity.

  pacomax likes this.


3289  2321  431  2921 

Top 10 Active Counters
 CELG 108.24+0.11 
 ACHN 6.760.00 
 AVP 5.60-0.05 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 PFE 38.475-1.685 
 ECA 3.79-0.25 
 F 8.935+0.045 
 VXRT 0.878+0.235 
 NIO 4.18+0.17 
Partners & Brokers